Vernal keratoconjunctivitis is a common health problem. the objective of this randomized, double blind is to comparison of the efficacy of mitomycin c 0.01% and dexamethason 0.1% in refractory keratoconjunctivitis. In this study 30 patients with refractory keratoconjunctivitis who to meet the Inclusion/exclusion criteria and randomly assigned into intervention or control group. The patients in the intervention group will receive mitomycin c 0.01%. The patients in the control group will receive dexamethason 0.1%. Outcome efficacy of drugs on symptom: photophobia, tearing, itching, discharge and sing: conjunctival injection, upper lid conjunctival hypertrophia, doctal keratitis, trantas dot, limbal edema compare together.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201110097743N1
Registration date:2012-02-29, 1390/12/10
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2012-02-29, 1390/12/10
Registrant information
Name
Nooshin Bazzazi
Name of organization / entity
Hamedan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
00988118282682-00988118215151
Email address
nezarat@basu.ac.ir
Recruitment status
Recruitment complete
Funding source
Hamedan University of Medical Sciences
Expected recruitment start date
2010-07-23, 1389/05/01
Expected recruitment end date
2012-07-22, 1391/05/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the efficacy of mitomycin c 0.01%versus dexamethason 0.1% in treatment of refractory in Vernal Keratoconjunctivitis keratoconjunctivitis
Public title
Comparison of mitomycin and dexametoson in Vernal Keratoconjunctivitis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion Criteria :the paitient with Refractory Vernal Keratoconjunctivitis.
Exclusion criteria :croneal and conjunctivitis complication due to mitomycin c 0.01% efficacy of drugs.
Age
From 6 years old to 75 years old
Gender
Both
Phase
4
Groups that have been masked
No information
Sample size
Target sample size:
30
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
-
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Hamedan University of Medical Sciences
Street address
Bolvar eram-Hamedan
City
Hamedan
Postal code
-
Approval date
2011-08-03, 1390/05/12
Ethics committee reference number
د/پ/16/35/9/786
Health conditions studied
1
Description of health condition studied
vernal keratoconjunctivitis
ICD-10 code
H 10.1
ICD-10 code description
vernal conjunctivitis
Primary outcomes
1
Description
Symptom: photophobia, tearing, itching, discharg to four grad: non complication, mild, modrat (complication half of day), sever (complication whole day)